Vogt-Koyanagi-Harada Disease and Systemic Lupus Erythematosus Occurring during Adalimumab Therapy for Ulcerative Colitis. 2020

Abdulrahman F AlBloushi, and Omar S Al-Hadlaq, and Faisal A AlRashed, and Ahmed M Abu El-Asrar
Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

We report the case of a 36-year-old male patient known to have ulcerative colitis on adalimumab treatment for 2 years who presented with initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease. Uveitis was treated successfully with systemic corticosteroids combined with mycophenolate mofetil. The patient had complete resolution of posterior segment inflammation and exudative retinal detachment. One year after the initial presentation, the patient was diagnosed to have systemic lupus erythematosus and adalimumab was discontinued. This case suggests that adalimumab could induce severe autoimmune inflammatory diseases.

UI MeSH Term Description Entries
D007208 Indocyanine Green A tricarbocyanine dye that is used diagnostically in liver function tests and to determine blood volume and cardiac output. Cardio-Green,Cardiogreen,Ujoveridin,Vofaverdin,Vophaverdin,Wofaverdin,Cardio Green,Green, Indocyanine
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D004396 Coloring Agents Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. Coloring Agent,Dye,Dyes,Organic Pigment,Stain,Stains,Tissue Stain,Tissue Stains,Organic Pigments,Pigments, Inorganic,Agent, Coloring,Inorganic Pigments,Pigment, Organic,Pigments, Organic,Stain, Tissue,Stains, Tissue
D005451 Fluorescein Angiography Visualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. It is used especially in studying the retinal and uveal vasculature. Fluorescence Angiography,Fundus Fluorescence Photography,Angiography, Fluorescein,Angiography, Fluorescence,Fluorescence Photography, Fundus,Photography, Fundus Fluorescence
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068879 Adalimumab A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS. Adalimumab-adbm,Adalimumab-atto,Amjevita,Cyltezo,D2E7 Antibody,Humira,Antibody, D2E7
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

Abdulrahman F AlBloushi, and Omar S Al-Hadlaq, and Faisal A AlRashed, and Ahmed M Abu El-Asrar
May 2009, Gastroenterologia y hepatologia,
Abdulrahman F AlBloushi, and Omar S Al-Hadlaq, and Faisal A AlRashed, and Ahmed M Abu El-Asrar
March 2007, Archivos de la Sociedad Espanola de Oftalmologia,
Abdulrahman F AlBloushi, and Omar S Al-Hadlaq, and Faisal A AlRashed, and Ahmed M Abu El-Asrar
February 2004, Southern medical journal,
Abdulrahman F AlBloushi, and Omar S Al-Hadlaq, and Faisal A AlRashed, and Ahmed M Abu El-Asrar
January 2021, Frontiers in medicine,
Abdulrahman F AlBloushi, and Omar S Al-Hadlaq, and Faisal A AlRashed, and Ahmed M Abu El-Asrar
November 2004, Journal of gastroenterology,
Abdulrahman F AlBloushi, and Omar S Al-Hadlaq, and Faisal A AlRashed, and Ahmed M Abu El-Asrar
January 2018, Ocular immunology and inflammation,
Abdulrahman F AlBloushi, and Omar S Al-Hadlaq, and Faisal A AlRashed, and Ahmed M Abu El-Asrar
January 1995, The British journal of ophthalmology,
Abdulrahman F AlBloushi, and Omar S Al-Hadlaq, and Faisal A AlRashed, and Ahmed M Abu El-Asrar
January 2014, Ophthalmic surgery, lasers & imaging retina,
Abdulrahman F AlBloushi, and Omar S Al-Hadlaq, and Faisal A AlRashed, and Ahmed M Abu El-Asrar
November 2015, Current opinion in ophthalmology,
Abdulrahman F AlBloushi, and Omar S Al-Hadlaq, and Faisal A AlRashed, and Ahmed M Abu El-Asrar
January 2005, International ophthalmology clinics,
Copied contents to your clipboard!